Comparative Effectiveness and Safety of Oral P2Y12 Inhibitors in Patients on Chronic Dialysis

Keyphrases

• Comparative Effectiveness 100%
• Chronic Dialysis 100%
• Prasugrel 100%
• P2Y12 Inhibitors 100%
• Comparative Safety 100%
• Clopidogrel 85%
• Dialysis 71%
• Ticagrelor 71%
• End-stage Kidney Disease 71%
• Risk Reduction 57%
• Coronary Revascularization 42%
• P2Y12 42%
• Gastrointestinal Hemorrhage 42%
• Propensity Matching 28%
• Hazard Ratio 14%
• Cardiovascular Mortality 14%
• Prescription Drugs 14%
• Medicare Beneficiaries 14%
• Survival Analysis 14%
• Risk of Death 14%
• United States Renal Data System (USRDS) 14%
• Adjusted Hazard Ratio 14%
• Exposure Parameters 14%
• Medication Classes 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Prasugrel 100%
• Clopidogrel 85%
• End Stage Renal Disease 71%
• Ticagrelor 71%
• Gastrointestinal Hemorrhage 42%

Biochemistry, Genetics and Molecular Biology

• Prasugrel 100%
• P2Y12 100%
• Clopidogrel 85%